Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aclarion Inc ACON

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the... see more

Recent & Breaking News (NDAQ:ACON)

Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants

TheNewsWire 4 days ago

Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants

TheNewsWire 7 days ago

Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market

TheNewsWire January 3, 2025

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

GlobeNewswire November 21, 2024

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Accesswire November 14, 2024

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire October 10, 2024

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

GlobeNewswire September 27, 2024

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

GlobeNewswire September 12, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Accesswire September 11, 2024

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

GlobeNewswire September 10, 2024

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

GlobeNewswire September 5, 2024

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

GlobeNewswire August 29, 2024

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

GlobeNewswire August 21, 2024

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

GlobeNewswire August 15, 2024

Aclarion Announces First Commercial Agreement in Michigan

GlobeNewswire August 14, 2024

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

GlobeNewswire August 13, 2024

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

GlobeNewswire July 9, 2024

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

GlobeNewswire June 26, 2024

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

GlobeNewswire June 25, 2024

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Accesswire April 29, 2024